Experienced in Anhidrosis

Beate Weigel-Schlotter

Munich, BY, DE 
Experienced in Anhidrosis
Munich, BY, DE 
OverviewLocationsClinical Research

Overview

Beate Weigel-Schlotter practices in Munich, Germany. Ms. Weigel-Schlotter is rated as an Experienced expert by MediFind in the treatment of Anhidrosis. Her top areas of expertise are Charcot-Marie-Tooth Disease, Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy Type 3, and Hereditary Sensory Neuropathy Type 1 (HSN1).

Her clinical research consists of co-authoring 22 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Anhidrosis.

Gender
Female

Locations

Munich, BY, Germany
Other Locations
Hamburg, HH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Enrollment Status: Completed
Publish Date: June 29, 2025
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Enrollment Status: Active_not_recruiting
Publish Date: April 03, 2024
Intervention Type: Drug
Study Drug: (RS)-Baclofen, Naltrexone Hydrochloride and D-Sorbitol
Study Phase: Phase 3
View 1 Less Clinical Trial

22 Total Publications

Complement profiling of sural nerves in chronic-inflammatory demyelinating polyneuropathy.
Complement profiling of sural nerves in chronic-inflammatory demyelinating polyneuropathy.
Journal: Acta neuropathologica
Published: May 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Weigel-Schlotter's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile